Australia markets open in 9 hours 59 minutes

Treace Medical Concepts, Inc. (TMCI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
15.40+0.17 (+1.12%)
As of 09:55AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 810.94M
Enterprise value 757.13M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.74
Price/book (mrq)9.34
Enterprise value/revenue 7.23
Enterprise value/EBITDA -33.99

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-52.89%
S&P500 52-week change 3-5.29%
52-week high 337.17
52-week low 312.48
50-day moving average 318.11
200-day moving average 320.83

Share statistics

Avg vol (3-month) 3229.41k
Avg vol (10-day) 3163.69k
Shares outstanding 555.28M
Implied shares outstanding 6N/A
Float 831.54M
% held by insiders 140.90%
% held by institutions 138.84%
Shares short (12 May 2022) 41.58M
Short ratio (12 May 2022) 46.29
Short % of float (12 May 2022) 47.07%
Short % of shares outstanding (12 May 2022) 42.86%
Shares short (prior month 13 Apr 2022) 41.17M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin -25.92%
Operating margin (ttm)-22.15%

Management effectiveness

Return on assets (ttm)-15.77%
Return on equity (ttm)-63.06%

Income statement

Revenue (ttm)104.76M
Revenue per share (ttm)1.99
Quarterly revenue growth (yoy)55.30%
Gross profit (ttm)76.59M
Net income avi to common (ttm)-27.19M
Diluted EPS (ttm)-0.52
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)98.48M
Total cash per share (mrq)1.78
Total debt (mrq)44.75M
Total debt/equity (mrq)51.55
Current ratio (mrq)8.28
Book value per share (mrq)1.57

Cash flow statement

Operating cash flow (ttm)-23.99M
Levered free cash flow (ttm)-17.73M